# Trade Mark Journal No.2026/024 12 June 2026

## WO0000001919643 (42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:29 August 2025
Date of designation in the UK: 29 August 2025

International priority date claimed: 4 March 2025 (European Union Intellectual Property Office (EUIPO)) (019150911)

Class 42
  Conducting clinical research and patient studies for pharmaceutical development; medical and scientific research, namely, the project management of clinical trials in the pharmaceutical, biotechnology and medical device fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical development services, namely, advising on and conducting all phases of clinical trials in the pharmaceutical, biotechnology and medical devices fields; scientific and medical research in the nature of clinical research and clinical trials in the fields of pharmacology, biotechnology and medical devices; laboratory research, namely, laboratory analysis of samples in the field of pharmaceuticals, biotechnology and medical devices; medical and scientific research in the field of medical imaging services; scientific, research and technological consulting services in the fields of clinical trials and clinical pharmacology, pharmaceutical and medical device market strategies; computer services in the nature of providing configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; providing online non-downloadable software, software as a services (SaaS) services featuring software and artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence for clinical development services, namely, hosting and management, electronic document and workflow management, providing clinical trial technology, providing research planning optimization, provision of platforms for healthcare data analytics and visualization; technical data analysis and artificial intelligence powered research, namely healthcare data analysis and information technology technical support services to analyze, integrate and manage healthcare data; scientific and technological services, namely, design and execution of clinical studies; providing technology solutions for healthcare support for clinical research, namely providing non-downloadable software applications, hosting a web portal, hosting an online platform for use in telemedicine and remote monitoring of patients to enable decentralized participation in clinical trials; providing technology solutions for healthcare support for clinical research, namely software as a service (SaaS) or platform as a service (PaaS) featuring software for transmission of images, audio-visual content, video content, messages, for managing and conducting meetings and collating data from patients for use in telemedicine and remote monitoring of patients to enable decentralized participation in clinical trials.
Class 44
  Medical services, namely, medical advice relating to adverse event evaluation and medical safety monitoring of clinical trials; medical information services, namely, providing medical information related to clinical trials; medical services provided in research settings, including operating and managing clinical trial sites, including fulfilling investigator duties and associated direct patient care services, administration of investigational treatments, medications or medical devices in research settings; healthcare support services for clinical research; home healthcare services for remote trial participants, including monitoring and drug administration.

ICON Clinical Research Limited

Representative: Morgan, Lewis & Bockius UK LLP, Condor House, 5-10 St. Paul's Churchyard London EC4M 8AL UNITED KINGDOM